References
- Reier PJ. Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx 2004; 1: 424–51
- Deng Y, Liu Y, Zhu W, et al. The co-transplantation of human bone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model. Cytotherapy 2008; 6: 551–64
- Deda H, Inci M, Kurekci A, et al. Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy 2008; 6: 565–74
- Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multi-potent stromal cells (MSCs): the state of transdifferentiation and modes of tissue repair – current views. Stem Cells 2007; 25: 2896–902
- Martino G, Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci 2006; 7: 395–406
- Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells: role in health and disease. Nat Rev Immunol 2008; in press.
- Rivera FJ, Couillard-Despres S, Pedre X, et al. Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells 2006; 24: 2209–19
- Bai L, Caplan A, Lennon D, Miller RH. Human mesenchymal stem cell signals regulate neural stem cell fate. Neurochem Res 2007; 32: 353–62